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Regulatory functions of alloreactive Th2 clones in human renal T cell recognition of alloantigen is the key primary
transplant recipients. event that initiates allograft rejection, although several
Background. Chronic allograft rejection is the major clinical other factors may contribute to acute and chronic allo-
problem in organ transplantation. There is evidence that indi- graft dysfunction [1–5]. T cells recognize alloantigen viarect T cell recognition of donor-specific HLA peptides may play
two distinct yet non-mutually exclusive pathways: the di-an important role in the immunopathogenesis of chronic allo-
rect and indirect pathways of allorecognition [2, 6]. Ingraft rejection. We have recently shown that HLA allopeptide-
specific T cell clones generated from renal transplant recipients the direct pathway, alloreactive T cells recognize intact
with chronic allograft nephropathy are of the Th1 phenotype, allo-major histocompatibility complex (MHC) molecules
while those from stable patients are Th2. There is evidence in on the surface of donor cells, while in the indirect path-
experimental animal models of autoimmunity and transplanta- way, T cells recognize alloantigens in the form of pep-tion that Th2 cells may function to regulate immune responses,
tides after processing and presentation by self-antigenbut the biological relevance of these observations in humans
presenting cells (APC’s). Experimental studies havehas not been reported.
shown that both pathways could mediate skin allograftMethods. The purpose of this study was to investigate the
putative regulatory functions of alloreactive human Th2 clones. rejection [7, 8]. However, it has been suggested that the
HLA-DR allopeptide-specific Th1 and Th2 cell clones were direct pathway of allorecognition predominantly medi-
generated from peripheral blood lymphocytes of human renal ates acute allograft rejection, while the indirect pathway
allograft recipients with chronic allograft nephropathy (CAN)
of allorecognition mediates chronic rejection of vascu-or with stable renal function (SRF), respectively.
larized grafts [2, 3]. Recent data from our group andResults. An in vitro co-culture system showed that the pro-
others in human renal, cardiac and lung allograft recipi-liferative responses of Th1 clones from patients with CAN were
significantly inhibited by the Th2 clones in response to the donor- ents support this hypothesis [9–13]. In experimental ani-
derived HLA allopeptides. In addition, co-culture of the Th2 mals, priming via the indirect pathway promotes devel-
clones inhibited cytokine production (IFN-) by the Th1 clones opment of chronic allograft vasculopathy in small and
in response to the donor-specific peptides. The regulatory func- large animal models [5, 14].tions of Th2 clones were antigen-specific since they only oc-
In a series of animal studies, we have shown that classcurred when both the Th1 and Th2 clones were reactive to the
II MHC allopeptide-specific T cell clones from rats withsame HLA-DR allopeptide, and were mediated by IL-4 and
acute rejection produce interferon- (IFN-), whereasIL-10.
Conclusions. This is the first demonstration, to our knowl- clones from tolerant animals produce interleukin (IL)-4
edge, indicating that Th2 cells may function to regulate indirect and IL-10 in response to the relevant allopeptide in vitro
Th1 alloimmune responses that are critical for the progression [15–17]. Adoptive transfer of T helper-1 (Th1) clones
of CAN in humans.
into naı¨ve LEW rats induced alloantigen-specific delayed
type hypersensitivity (DTH) responses, while transfer of
Th2 clones did not. Co-adaptive transfer of the Th1 andKey words: regulatory cells, T cell lines, cell clones, cytokines, renal
Th2 clones suppressed DTH responses to the allopeptidetransplantation, chronic allograft nephropathy, peptides, HLA, organ
rejection. and irradiated donor splenocytes. In vitro, irradiated Th2
clones inhibited the proliferative response of the Th1Received for publication October 15, 2001
clones and suppressed IFN- production. In our pilotand in revised form February 15, 2002
Accepted for publication March 8, 2002 study in human transplant recipients the HLA-DR allo-
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with chronic allograft nephropathy (CAN) secreted Th1 Enzyme-linked immunosorbent spot (ELISPOT) assay
cytokines, whereas clones from patients with stable renal The ELISPOT assay was used to measure the fre-
function (SRF) produced Th2 cytokines in response to quency of alloreactive T cell clones producing the Th1
donor-specific HLA-DR allopeptides [17]. The aim of cytokine IFN- and the Th2 cytokine IL-10, as previously
our current study was to investigate the regulatory func- described [18]. Briefly, ELISPOT plates [Cellular Tech-
tions of Th2 clones generated from human renal trans- nology Limited (CTL), Cleveland, OH, USA] were
plant recipients, and to prove the biologic relevance of coated with capture antibodies against INF- or IL-10
these experimental findings in animals into humans. (Endogen, Rockford, IL, USA) in phosphate-buffered
saline (PBS) and left overnight at 4C. The plates were
blocked with PBS-bovine serum albumin (BSA) 1% forMETHODS
one hour and then washed with PBS. A total of 5  105
Patients peripheral blood leukocyte (PBL) were added to each
The renal transplant recipients who were used to gen- well in 100 L of complete RPMI medium [90% RPMI,
10% human serum (Sigma, St. Louis, MO, USA); l-glu-erate the T cell clones were previously described [9, 17].
tamine and penicillin/streptomycin (BioWhittaker, Walk-Briefly, renal allograft recipients who had received their
ersville, MD, USA); 50 mmol/L 2-mercaptoethanoltransplants at least six months earlier and were attending
(Sigma)] and the relevant HLA-DR peptide. Controlthe renal transplant clinic at the Brigham and Women’s
wells contained cells plus medium alone or APCs withoutHospital were screened. All patients were on triple ther-
the peptide. After 48 hours, the plates were washed,apy immunosuppression consisting of cyclosporine, ste-
biotinylated detection antibodies added and the platesroids, and azathioprine. Patients of specific interest had
were left for a further overnight incubation at 4C. Afterto be mismatched for one or more of the three candidate
further washing, HRP conjugate (Dako, Glostrup, Den-HLA-DR antigens for which synthetic peptides were avail-
mark) was added for two hours at room temperature.able (DR1, DR2, and DR3). Two patients with biopsy-
Development was with AEC (Pierre Pharmaceuticals,proven chronic allograft nephropathy with an elevated
Rockland, IL, USA; 10 mg/mL in N,N-dimethylform-serum creatinine level (2.0 mg/dL) were compared with
amide) freshly prepared in 0.1 mol/L sodium acetatethree patients with stable allograft function (stable serum
buffer (pH 5.0) mixed with 30% H2O2 (200 L per well).creatinine 2.0 mg/dL). The study was approved by the
The resulting spots were counted on a computer-assistedhuman subjects committee of the Brigham and Women’s
ELISPOT Image Analyzer (CTL; Fig. 1). The resultsHospital.
were then calculated and presented as the frequency of
cytokine-producing cells per million cells.Peptides
A panel of peptides corresponding to the -chain hy- Proliferation assay
pervariable regions of HLA-DRB*0101 (residues 6-21,
T cell clones (2.5 104 cells) were cultured with 10 g22-41, 42-62, 63-80, 81-94), HLA-DRB*1501 (residues
of the relevant donor mismatched HLA-DR allopep-1-21, 22-40, 41-60, 61-80, 81-94), and HLA-DRB*0301
tide in the presence of irradiated APCs for 72 hours. Hu-
(residues 6-21, 22-41, 42-62, 63-80, 81-94) was synthe-
man neutralizing antibodies, rat anti-human IL-4 mono-
sized (Quality Controlled Biochemicals, Hopkinton, MA, clonal antibodies (mAb; 0.5 to 25g/mL), rat anti-human
USA) as previously described [9, 17]. IL-10 mAb (0.5 to 25g/mL), or rat IgG1 isotope control
antibody (all from PharMingen, San Diego, CA, USA)Generation of T cell lines and clones
were added to the cultures. As the optimal effects of anti-
The generation and characterization of the human Th1 IL-4 and anti-IL-10 mAb were observed at a concentra-
and Th2 cell clones used in this study was previously tion of 10 g/mL, that dose was used for anti-IL-4, anti-
described [17]. Two cell lines (Th1) were obtained from IL-10, and isotope control antibodies in the experiments.
the patients with CAN and three cell lines (Th2) were Lymphocyte proliferation was determined by measuring
obtained from the stable patients. A total of eleven (Th1) the 3H thymidine incorporation [17]. In the co-culture
and twenty (Th2) T cell clones were generated, respec- system, irradiated (3000 Rads) Th2 clones (2.5  104)
tively, by limiting the dilution as previously described were incubated with an equal number of the Th1 clones
[17]. Of these, four Th1 clones with different T cell recep- (2.5 104) and the relevant HLA-DR allopeptide. Back-
tor phenotypes derived from one cell line and reactive to ground proliferation was assessed by incubating the cells
HLA-DRB*0101 (residues 42-62) were studied along with with culture media alone without the peptides.
three Th2 clones reactive to the same peptide and three
Enzyme-linked immunosorbent assay (ELISA)Th2 clones reactive to HLA-DRB*1501 (residues 41-60).
Similar results were obtained in all experiments and rep- Supernatants from T clones were cultured with 10 g
of donor specific allopeptide and with the neutralizingresentative data are shown from one set of studies.
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Fig. 2. Regulatory function of Th2 clones. Proliferation assay of co-
culture of Th2 clones from patients with stable renal function (SRF)
irradiated with 3000 rads, cultured in a 1:1 ratio with Th1 clones from
chronically rejecting patients (CR). (1) Th1 clones specific for HLA-
DR1 (42-62)  peptide HLA-DR1 (42-62). (2) Irradiated Th2 clones
specific for HLA-DR2 (41-60)  peptide HLA-DR2 (41-60). (3) Th1
clones specific for HLA-DR1 (42-62)  irradiated Th2 clones specific
for HLA-DR2 (41-60)  peptide HLA-DR1 (42-62). (4) Th1 clones
specific for HLA-DR1 (42-62)  irradiated Th2 clones specific for
HLA-DR2 (41-60)  peptides HLA-DR1 (42-62) and HLA-DR2 (41-
60). (5 ) Th1 clones specific for HLA-DR1 (42-62)  irradiated Th2
clones specific for HLA-DR2 (41-60)  peptides HLA-DR1 (42-62)
and HLA-DR2 (41-60), and neutralizing IL-4 mAb. (6 ) Th1 clones
specific for HLA-DR1 (42-62)  irradiated Th2 clones specific for
HLA-DR2 (41-60)  peptides HLA-DR1 (42-62) and HLA-DR2 (41-
60), and neutralizing IL-10 mAb. (7 ) Th1 clones specific for HLA-Fig. 1. ELISPOT analysis of T cell clones from renal transplant patients
DR1 (42-62)  irradiated Th2 clones specific for HLA-DR2 (41-60) generated with donor specific HLA-DR allopeptides. (A) Interfe-
peptides HLA-DR1 (42-62) and HLA-DR2 (41-60), and neutralizingron- (IFN-) and (B) interleukin (IL)-10 of a representative T cell
anti-IL-4 and anti-IL-10 mAb. Data are expressed as mean 	 SEM;clone from a patient with chronic rejection (Th1 clone); (C ) IFN- and
*P  0.0001, 1 vs. 4; N 
 4.(D) IL-10 of a representative T cell clone from a patient with stable
renal function (Th2 clone). Symbols are: ( ) control peptide; () allo-
peptide; () no peptide.
tested from each of the patients and similar results were
obtained in all cases.
anti-IL-4 mAb, anti-IL-10 mAb, or rat IgG1 isotope con- We then investigated whether the Th2 clones function
trol were obtained at 48 hours for measuring the level to regulate Th1 alloimmune responses. The regulatory
of secreted Th1 (IFN-, IL-2) and Th2 (IL-4, IL-10) cy- functions of Th2 clones have been described in both
tokines. Cytokine production was measured by ELISA experimental autoimmune [19, 20] and transplant animal
using BioSource Cytoscreen Kits (BioSource, Camarillo, models [17], but have not as of yet been demonstrated in
CA, USA), as previously described [17]. humans. Therefore, a co-culture system was established
where Th1 and irradiated (to prevent their proliferation)
Th2 clones were incubated in vitro with the relevantRESULTS
HLA-DR allopeptide. Figure 2 shows that the addition
In a recent study we generated T cell lines and clones of the irradiated Th2 clones significantly inhibited the
from peripheral blood lymphocytes of renal transplant proliferative response of the Th1 clones (by 57%) to
recipients against donor-derived HLA-DR peptides pre- the relevant HLA-DR allopeptide. The irradiated Th2
sented by self antigen-presenting cells [17]. We showed clones alone had minimal proliferation in response to
that the T cell clones generated from patients with CAN the HLA-DR allopeptide, ruling out the possibility that
were of the Th1 phenotype, while those generated from the inhibition of proliferation in the co-culture system
stable patients were Th2. In our current study ELISPOT was due to overcrowding of cells or over-consumption
analysis was used first to confirm these results. As shown of growth media in culture wells. In addition, inhibition
in Figure 1 T cell clones generated from patients with of proliferation did require the presence of the relevant
CAN produced IFN- (prototype Th1 cytokine), while HLA-DR peptide to stimulate the Th2 clones to regulate
those generated from stable patients produced IL-10 (pro- the Th1 clones in vitro (Fig. 2).
totype Th2 cytokine) in response to the donor-derived Then the effects of Th1 and Th2 cell interactions on cy-
mismatched HLA-DR allopeptide in vitro. Three or four tokine production were evaluated in vitro using ELISA.
Cytokine analysis of co-culture supernatants showed in-clones with different T cell receptor phenotypes were
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Fig. 3. Regulatory function of Th2 clones.
Cytokine profiles of co-culture supernatants
of Th2 clones from patients with stable renal
function (SRF) irradiated with 3000 rads, cul-
tured in a 1:1 ratio with Th1 clones from chron-
ically rejecting patients (CR). Symbols are:
() IFN-; ( ) IL-2; ( ) IL-4; () IL-10. (1)
Th1 clones specific for HLA-DR1 (42-62) 
peptide HLA-DR1 (42-62). (2) Irradiated Th2
clones specific for HLA-DR2 (41-60)  pep-
tide HLA-DR2 (41-60). (3) Th1 clones specific
for HLA-DR1 (42-62) irradiated Th2 clones
specific for HLA-DR2 (41-60)  peptide
HLA-DR1 (42-62). (4) Th1 clones specific for
HLA-DR1 (42-62)  irradiated Th2 clones
specific for HLA-DR2 (41-60)  peptides
HLA-DR1 (42-62) and HLA-DR2 (41-60). (5)
Th1 clones specific for HLA-DR1 (42-62) 
irradiated Th2 clones specific for HLA-DR2
(41-60)  peptides HLA-DR1 (42-62) and
HLA-DR2 (41-60), and neutralizing IL-4
mAb. (6) Th1 clones specific for HLA-DR1
(42-62)  irradiated Th2 clones specific for
HLA-DR2 (41-60)peptides HLA-DR1 (42-
62) and HLA-DR2 (41-60), and neutralizing
IL-10 mAb. (7) Th1 clones specific for HLA-
DR1 (42-62)  irradiated Th2 clones specific
for HLA-DR2 (41-60)  peptides HLA-DR1
(42-62) and HLA-DR2 (41-60), and neutraliz-
ing anti-IL-4 and anti-IL-10 mAb. Data are
expressed as mean 	 SEM, *Reduction in
IFN-, 1 vs. 4, P  0.0001, N 
 4).
hibition of IFN- (by 46%) but not of IL-2 production dissect the mechanisms of regulation, proliferation of
by the Th1 clones in the presence of Th2 clones in re- and cytokine production by the Th1 co-cultured with
sponse to the relevant HLA-DR peptide (Fig. 3). These Th2 cell clones were measured in the presence or absence
data indicate that there is a dissociation between the of neutralizing anti-IL-4, anti-IL-10 mAb, or isotope-
inhibition of Th1 cell proliferation and IFN- production matched control. With the presence of the neutralizing
on the one hand and IL-2 secretion on the other. This anti-IL-4 mAb the proliferative response of the co-cul-
is an interesting observation. We are uncertain whether tured Th1 and Th2 cell clones was enhanced compared
this is unique to our indirectly primed T cells clones, and to the response in absence of the antibody. However,
if so, what the mechanism for this would be. Clearly, this response was lower than the normal response of Th1
proliferation is not dependent solely on IL-2 in these cell clones alone. A comparable effect was observed when
clones; however, we are uncertain of the exact relation- neutralizing anti-IL-10 mAb was added. However, addi-
ship of INF- and proliferation other than to say that tion of both neutralizing antibodies (anti-IL-4 and anti-
they are both impaired by co-culture with the Th2 clones. IL-10) to co-cultured Th1 and Th2 cell clones fully re-
Similar to the proliferation studies described above, ad- stored the T cell proliferative response; indeed the prolif-
dition of Th2 clones with different peptide specificity did erative responses were slightly higher than the Th1 clone
not result in inhibition of cytokine production (Fig. 3). alone (Fig. 2). Furthermore, as shown in Figure 3, neu-
As expected, production of the Th2 cytokines IL-4 and tralizing anti-IL-4 or anti-IL-10 mAb failed to normalize
IL-10 by the irradiated Th2 clones was preserved and was IFN- production by Th1 and Th2 co-cultured cell clones.
not affected by co-culture with the Th1 clones (Fig. 3). However, when both of the neutralizing antibodies (anti-
Although irradiation reduced the ability of Th2 clones IL-4 and anti-IL-10) were added to the Th1 and Th2
to proliferate, irradiated clones were still able to produce co-culture the production of IFN- was restored. The
IL-4 and IL-10 in response to appropriate antigenic stim- control antibodies had little effect (data not shown).
ulation. As cytokine production and cell proliferation are
two different functions of the T cell response to antigen,
DISCUSSIONthey may respond differently to irradiation. Previous pub-
Collectively, our data clearly demonstrate, to our knowl-lications have shown the differential effects of irradiation
edge for the first time, a regulatory function of HLA-on the ability of T cells to proliferate and produce cyto-
kines [21]. To further confirm these results and further DR allopeptide-specific Th2 cell clones in humans and
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4. Waaga AM, Gasser M, Laskowski I, Tilney NL: Mechanisms ofconfirm our previous similar findings in an animal model.
chronic rejection. Curr Opin Immunol 12:517–521, 2000
The Th1 clones in the animal study were derived from 5. Womer KL, Stone JR, Murphy B, et al: Indirect allorecognition
of donor class I and II major histocompatibility complex peptidesacutely rejecting recipients of a renal allograft, while in
promotes the development of transplant vasculopathy. J Am Socthis study the human Th1 clones were derived from indi-
Nephrol 12:2500–2506, 2001
viduals undergoing chronic rejection. This suggests that 6. Benichou G, Tam RC, Soares LRB, Fedoseyeva EV: Indirect
T-cell allorecognition: Perspectives for peptide-based therapy inthe biological process of indirect allorecognition in both
transplantation. Immunol Today 18:67–71, 1997acute and chronic rejection are similar, but may differ
7. Auchincloss HJ, Lee R, Shea S, et al: The role of “indirect”
quantitatively rather than qualitatively, with a lower al- recognition in initiating rejection of skin grafts from major histo-
compatibility complex class II-deficient mice. Proc Natl Acad Sciloreactive T cell clone frequency occurring in chronic
USA 90:3373–3377, 1993rejection. The importance of Th2 clones in tolerant and
8. Valujskikh A, Matesic D, Gilliam A, et al: T cells reactive to a
benign responses to alloantigen has been debated, and single immunodominant self-restricted allopeptide induce skin
graft rejection in mice. J Clin Invest 101:1398–1407, 1998evidence in the literature suggesting that deviation to a
9. Vella JP, Spadafora-Ferreira M, Murphy B, et al: Indirect allo-Th2 phenotype is either a cause or an effect of a tolerant
recognition of major histocompatibility complex allopeptides in
response remains controversial. In an interesting study, human renal transplant recipients with chronic graft dysfunction.
Transplantation 64:795–800, 1997Li et al showed that inhibiting Th1 responses by a neu-
10. Ciubotariu R, Liu Z, Colovai AI, et al: Persistent allopeptidetralizing anti-IL-12 antibody was effective in inhibiting
reactivity and epitope spreading in chronic rejection of organ allo-
alloimmune responses to minor but not major histo- grafts. J Clin Invest 101:398–405, 1998
11. Hornick PI, Mason PD, Yacoub MH, et al: Assessment of theincompatibility antigens [22]. The authors suggested that
contribution that direct allorecognition makes to the progressionone potential explanation is that Th2 immune deviation
of chronic cardiac transplant rejection in humans. Circulation 97:
may be more effective in inhibiting an indirect allo- 1257–1263, 1998
12. Hornick PI, Mason PD, Baker RJ, et al: Significant frequenciesimmune response where the alloreactive T cell clone size
of T cells with indirect anti-donor specificity in heart graft recipientsis relatively small. However, data indicating that a Th2
with chronic rejection. Circulation 101:2405–2410, 2000
clone can regulate a Th1 alloimmune response in vivo 13. SivaSai KS, Smith MA, Poindexter NJ, et al: Indirect recognition
of donor HLA class I peptides in lung transplant recipients with bron-have been lacking. Besides our initial results in animals
chiolitis obliterans syndrome. Transplantation 67:1094–1098, 1999[17], VanBuskirk and colleagues recently published data
14. Lee RS, Yamada K, Houser, et al: Indirect recognition of allopep-
indicating that peripheral blood lymphocytes from trans- tides promotes the development of cardiac allograft vasculopathy.
Proc Natl Acad Sci USA 98:3276–3281, 2001plant patients off immunosuppression with stable allo-
15. Chen W, Murphy B, Waaga AM, et al: Mechanisms of indirectgraft function can function as regulatory cells whose
allorecognition in graft rejection: Class II MHC allopeptide-specific
function may be mediated through IL-10 and trans- T cell clones transfer delayed-type hypersensitivity responses in
vivo. Transplantation 62:705–710, 1996forming growth factor- (TGF-) [23]. Our data further
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acute allograft rejection. Transplantation 65:876–883, 1998while an indirect Th2 alloimmune response may be regu-
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